DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Coleman RL. et al
VELIA/GOG-3005: Integration of veliparib with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin.
ESMO 2019 Abstract LBA3 und New Engl J Med published September 28, 2019 DOI: 10.1056/NEJMoa1909707
Access:
We do not assume any responsibility for the contents of the web pages of other providers.